Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Genentech beats Street EPS

DNA posted 3Q07 non-GAAP diluted EPS of $0.73, beating by a penny the Street's estimate of $0.72 and up 24% from $0.59 in

Read the full 235 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE